| 摘要 |
The invention relates to ethyl cysteinate and its pharmaceutically or cosmetically acceptable salts as new industrial products. These compounds, and in particular the salicylate and ascorbate of ethyl cysteinate, find application in the manufacture of pharmaceutical or cosmetic compositions intended, in particular, for the treatment of inflammatory rheumatic disorders or degenerative rheumatic disorders, as well as for the treatment of cataracts.
|
